SYSTEMATIC REVIEW
Accepted on 17 Apr 2025
Efficacy and safety of CD19 combined with CD22 or CD20 chimeric antigen receptor T-cell therapy for hematological malignancies
doi 10.3389/fimmu.2025.1577360
- 165 views
- Frontiers in Immunology
- T Cell Biology
- Research Topics
- Evolving Therapeutic Landscape of Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapies
Evolving Therapeutic Landscape of Bispecific Antibodies and Chimeric Antigen Receptor T-Cell Therapies
588
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.